These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28404639)

  • 1. Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH.
    Ioannou GN; Subramanian S; Chait A; Haigh WG; Yeh MM; Farrell GC; Lee SP; Savard C
    J Lipid Res; 2017 Jun; 58(6):1067-1079. PubMed ID: 28404639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis.
    Ioannou GN; Haigh WG; Thorning D; Savard C
    J Lipid Res; 2013 May; 54(5):1326-34. PubMed ID: 23417738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH.
    Ioannou GN; Van Rooyen DM; Savard C; Haigh WG; Yeh MM; Teoh NC; Farrell GC
    J Lipid Res; 2015 Feb; 56(2):277-85. PubMed ID: 25520429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.
    Chen HW; Yen CC; Kuo LL; Lo CW; Huang CS; Chen CC; Lii CK
    Toxicol Appl Pharmacol; 2020 Apr; 393():114941. PubMed ID: 32126212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic Steatohepatitis.
    Ioannou GN; Landis CS; Jin GY; Haigh WG; Farrell GC; Kuver R; Lee SP; Savard C
    Hepatol Commun; 2019 Jun; 3(6):776-791. PubMed ID: 31168512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol.
    Henkel J; Coleman CD; Schraplau A; Jӧhrens K; Weber D; Castro JP; Hugo M; Schulz TJ; Krämer S; Schürmann A; Püschel GP
    Mol Med; 2017 May; 23():70-82. PubMed ID: 28332698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages.
    McGettigan B; McMahan R; Orlicky D; Burchill M; Danhorn T; Francis P; Cheng LL; Golden-Mason L; Jakubzick CV; Rosen HR
    Hepatology; 2019 Jul; 70(1):67-83. PubMed ID: 30516830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
    He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
    Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
    Farrell GC; Haczeyni F; Chitturi S
    Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol.
    Ioannou GN; Lee SP; Linsley PS; Gersuk V; Yeh MM; Chen YY; Peng YJ; Dutta M; Mascarinas G; Molla B; Cui JY; Savard C
    Hepatol Commun; 2022 Apr; 6(4):780-794. PubMed ID: 34816633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
    Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
    J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
    Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
    Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Cholesterol in the Pathogenesis of NASH.
    Ioannou GN
    Trends Endocrinol Metab; 2016 Feb; 27(2):84-95. PubMed ID: 26703097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.
    Liu J; Wang T; He K; Xu M; Gong JP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Cholesterol-Associated Steatohepatitis in the Development of NASH.
    Horn CL; Morales AL; Savard C; Farrell GC; Ioannou GN
    Hepatol Commun; 2022 Jan; 6(1):12-35. PubMed ID: 34558856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NFκB signaling.
    Jiang X; Zhang F; Ji X; Dong F; Yu H; Xue M; Qiu Y; Yang F; Hu X; Bao Z
    Cytokine; 2021 Jun; 142():155474. PubMed ID: 33647584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
    Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
    Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation.
    Diehl KL; Vorac J; Hofmann K; Meiser P; Unterweger I; Kuerschner L; Weighardt H; Förster I; Thiele C
    Cells; 2020 Oct; 9(10):. PubMed ID: 33050035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin.
    Ni Y; Nagashimada M; Zhan L; Nagata N; Kobori M; Sugiura M; Ogawa K; Kaneko S; Ota T
    Endocrinology; 2015 Mar; 156(3):987-99. PubMed ID: 25562616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.